Glasgow Caledonian University spin-off company, Biopta, was used as a backdrop for an announcement by Scotland’s First Minister, Alex Salmond, that more than £4.7 million of European funding is being invested in initiatives to support small and medium enterprises.
Biopta, which was set-up by Dr. David Bunton and Professor Chris Hillier in 2002, now employs 18 people in testing drugs for the pharmaceutical industry using ethically sourced human tissue.
The firm has benefited from investment of more than £2million from a combination of GCU, Scottish Enterprise’s Proof of Concept Award and the Scottish Co-Investment Fund through matched investment from Braveheart Investment Group and TriCap.
Speaking today, the First Minister congratulated Biopta on being a further example of Scotland’s great innovation traditions, adding that the company counts eight of the top 10 pharmaceutical companies in the world among its clients.
Find out more about our business successes.